SMARCB1/INI1 inactivation in renal medullary carcinoma. - Wikidata - wikimedia - TriplyDB

SMARCB1/INI1 inactivation in renal medullary carcinoma.

SMARCB1/INI1 inactivation in renal medullary carcinoma.

http://www.wikidata.org/entity/Q54305674

about

Gene of the month: SMARCB1 SWI/SNF chromatin remodeling complexes and cancer Novel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumors Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC.Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.Proximal-type Epithelioid Sarcoma of the Head and Neck (HN): A Study with Immunohistochemical and Molecular Analysis of SMARCB1.Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma.Biology and Treatment of Rhabdoid Tumor.Renal Medullary Carcinoma: Establishing Standards in Practice.Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact.Renal cancer subtypes: Should we be lumping or splitting for therapeutic decision making?An Xp11.2 translocation renal cell carcinoma with SMARCB1 (INI1) inactivation in adult end-stage renal disease: a case report Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.High-Resolution Genomic Analysis of Cribriform Neuroepithelial Tumors of the Central Nervous System.Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression.A New Chromatin-Cytoskeleton Link in Cancer.Immune checkpoint inhibitors in renal cell carcinoma.SMARCB1-deficient Tumors of Childhood: A Practical Guide.SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.Renal medullary carcinoma: a nearly fatal malignancy specifically affecting patients with a so-called benign condition.Fine-needle-aspiration cytology of a proximal type epithelioid sarcoma: A case report.

P2860

Q26768682-509E7347-AFBE-47A1-9703-5B1FCDB6C39E Q26998657-9FF07F79-A5D2-456C-8969-F9A3B722CD28 Q27001114-8C2690B0-489B-4944-98D6-53668530D140 Q33583093-611C118A-5AAD-4F5D-9D0E-A023445D2558 Q34145962-001A7470-3ABF-46EC-AA8F-E68C4CA8A2FC Q35051968-786704CC-E102-4E3E-826B-3E7A0264AF1B Q37196827-17303AAB-73B1-4ADD-9485-6470B2F2EAA1 Q37355163-1CDFDCFB-082C-4EF9-8123-B252FF847447 Q37589140-4E8CCB80-E107-42AD-A1BD-CAF13CBEDA55 Q38582867-7CB4FA1D-F35D-4977-A7A3-F1109033F924 Q38684022-81F0D9F6-6B86-4643-B283-113C05E8E0E5 Q38910995-88B97799-A260-48BA-9082-319B5CE59B34 Q39012781-8E093BAF-B4B4-49AE-B7E3-A390F52F49C4 Q39298566-EFF608BA-C4CB-411A-9985-C029A9FCB54F Q40180205-2399735A-8743-431E-8EFF-3AEF9402CCB2 Q40558893-438C768C-3B7D-45D2-B299-04840F5EA9D6 Q41703426-291F2C1B-DC77-4B6F-9BF8-D6AC25941089 Q41835725-37B3E5C9-49DE-45FE-90A8-60261B3E7E5D Q46145782-F1AE62EA-A72D-46A0-9A1B-F731838E3CFB Q47592718-7B382908-C12A-4F88-B792-5DBD389F3D68 Q47894129-853EC04F-8411-479E-B695-BACA9020D438 Q48137036-4C0E9CE3-0DB8-407A-B457-793F0DF618B5 Q49355768-BE5E255D-457C-4132-9381-47A65A42EEB2 Q54596617-9909C242-7A71-4C0C-BADE-D03B4D37A98B

P2860

SMARCB1/INI1 inactivation in renal medullary carcinoma.

http://www.wikidata.org/entity/Q54305674

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@en

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@nl

type

label

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@en

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@nl

prefLabel

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@en

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@nl

P1433

Q54305674-629F02A7-FE59-402B-A07D-FA07DABE9A2C

P1476

Q54305674-C3AF89DD-E65F-4AED-91A7-57A7E98B082A

P2093

Q54305674-1A774E7D-4EAA-432C-912E-50A378387A98

Q54305674-1BEF022F-7C29-47B7-94E6-7623F63AA247

Q54305674-5AE564C8-EC37-4859-9BC4-3AC300903C6F

Q54305674-5DEE942A-3049-4176-84E3-9F5C835FB268

Q54305674-74423D6B-420F-425B-A264-4312DABB4D6D

Q54305674-7AF1E6D4-0825-4CB4-A0FE-1C3ED57A323D

Q54305674-7EAD3C52-9DF4-4D23-8101-CA18B9C58FD8

Q54305674-840C40EE-4DE8-4562-81E2-8BA7F0AFD74B

Q54305674-944E55EC-DD43-430C-9CC6-474B4B82E7DD

Q54305674-AFE755D6-F219-47CC-AC2D-8D828582E3B3

P2860

Q54305674-01A486CF-A672-43A2-A856-BAE961D1C0ED

Q54305674-01E9A8F0-182B-4031-8728-4F7A13737675

Q54305674-03FC7D9A-D28D-4C49-B3B2-D3FA1DAFA3B3

Q54305674-0CAA7B7A-6F58-42EB-AD7A-696CB084D500

Q54305674-2DC0CD11-9928-4954-A31A-10D9D6FD7DEF

Q54305674-3C6242E4-57AB-4D48-AEBD-2A96BC410779

Q54305674-3CE63251-080A-436D-AE3A-D229A0B2CDF2

Q54305674-4922A397-A4C1-44D6-B592-5BA93F514683

Q54305674-5F06D8C2-305A-4DE8-993B-6B199DFC8712

Q54305674-75D66267-0C22-46D3-9FB0-05C00D6917BC

P304

Q54305674-4164A885-A4AC-44A5-A77F-769F6612E586

P31

Q54305674-A461A443-DB75-4A4C-A05F-FF7B9F255333

P356

Q54305674-1E2E235A-7B29-4A03-95FF-3492C68DF7C3

P433

Q54305674-2693EC4F-7CFB-4DD7-BE8B-548142A12C17

P478

Q54305674-B48CF776-8855-45EC-8560-BE1BB7B6E5EA

P50

Q54305674-1EF59BA0-2A67-48B9-AA7E-470D64576DB4

P577

Q54305674-C723AB98-BC71-4A56-9B3A-A0B65D301A63

P698

Q54305674-4AE037FF-A5FC-4494-8962-CE570569BE95

P356

J.1365-2559.2012.04228.X

P1433

P1476

SMARCB1/INI1 inactivation in renal medullary carcinoma.

@en

P2093

Alexandre de la Taille

http://www.w3.org/2001/XMLSchema#string

Annick Vieillefond

http://www.w3.org/2001/XMLSchema#string

Camille Grison

http://www.w3.org/2001/XMLSchema#string

Florence Pedeutour

http://www.w3.org/2001/XMLSchema#string

Gaelle Pierron

http://www.w3.org/2001/XMLSchema#string

Julien Calderaro

http://www.w3.org/2001/XMLSchema#string

Julien Moroch

http://www.w3.org/2001/XMLSchema#string

Jérome Couturier

http://www.w3.org/2001/XMLSchema#string

Marie Christine Rousselet

http://www.w3.org/2001/XMLSchema#string

Pascale Maillé

http://www.w3.org/2001/XMLSchema#string

P2860

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

ALK rearrangement in sickle cell trait-associated renal medullary carcinoma

Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice

Gene expression profiling of renal medullary carcinoma: potential clinical relevance.

SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas.

Renal medullary carcinoma: report of seven cases from Brazil.

The theoretical basis of transcriptional therapy of cancer: can it be put into practice?

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies.

hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities.

P304

428-435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2559.2012.04228.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Delattre

P577

2012-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22686875

http://www.w3.org/2001/XMLSchema#string